vs

Side-by-side financial comparison of AMERICOLD REALTY TRUST (COLD) and NEUROCRINE BIOSCIENCES INC (NBIX). Click either name above to swap in a different company.

NEUROCRINE BIOSCIENCES INC is the larger business by last-quarter revenue ($814.5M vs $577.9M, roughly 1.4× AMERICOLD REALTY TRUST). NEUROCRINE BIOSCIENCES INC runs the higher net margin — 24.3% vs -2.4%, a 26.7% gap on every dollar of revenue. On growth, NEUROCRINE BIOSCIENCES INC posted the faster year-over-year revenue change (42.2% vs -1.2%). Over the past eight quarters, NEUROCRINE BIOSCIENCES INC's revenue compounded faster (17.5% CAGR vs -5.4%).

Americold Realty Trust, Inc. is an American temperature controlled warehousing and transportation company based in Atlanta, Georgia, United States. It is in the business of modern commercialized temperature controlled warehousing for the storage of perishable goods via a cold chain, one of the forms of food preservation. Americold is the 2nd largest temperature-controlled warehousing and distribution services provider in the world.

Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).

COLD vs NBIX — Head-to-Head

Bigger by revenue
NBIX
NBIX
1.4× larger
NBIX
$814.5M
$577.9M
COLD
Growing faster (revenue YoY)
NBIX
NBIX
+43.5% gap
NBIX
42.2%
-1.2%
COLD
Higher net margin
NBIX
NBIX
26.7% more per $
NBIX
24.3%
-2.4%
COLD
Faster 2-yr revenue CAGR
NBIX
NBIX
Annualised
NBIX
17.5%
-5.4%
COLD

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
COLD
COLD
NBIX
NBIX
Revenue
$577.9M
$814.5M
Net Profit
$-13.7M
$197.9M
Gross Margin
98.3%
Operating Margin
2.5%
23.7%
Net Margin
-2.4%
24.3%
Revenue YoY
-1.2%
42.2%
Net Profit YoY
16.9%
EPS (diluted)
$-0.05
$1.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLD
COLD
NBIX
NBIX
Q2 26
$814.5M
Q1 26
$577.9M
Q4 25
$643.1M
$805.5M
Q3 25
$649.0M
$794.9M
Q2 25
$635.1M
$687.5M
Q1 25
$613.7M
$572.6M
Q4 24
$647.4M
$627.7M
Q3 24
$660.4M
$622.1M
Net Profit
COLD
COLD
NBIX
NBIX
Q2 26
$197.9M
Q1 26
$-13.7M
Q4 25
$-88.3M
$153.7M
Q3 25
$-11.4M
$209.5M
Q2 25
$1.5M
$107.5M
Q1 25
$-16.4M
$7.9M
Q4 24
$-36.2M
$103.1M
Q3 24
$-3.7M
$129.8M
Gross Margin
COLD
COLD
NBIX
NBIX
Q2 26
98.3%
Q1 26
Q4 25
31.3%
97.8%
Q3 25
29.3%
98.2%
Q2 25
30.9%
98.4%
Q1 25
31.1%
98.4%
Q4 24
29.7%
98.5%
Q3 24
29.6%
98.7%
Operating Margin
COLD
COLD
NBIX
NBIX
Q2 26
23.7%
Q1 26
2.5%
Q4 25
-10.8%
26.2%
Q3 25
2.6%
30.1%
Q2 25
5.9%
21.2%
Q1 25
3.6%
4.1%
Q4 24
-1.8%
22.6%
Q3 24
4.6%
29.5%
Net Margin
COLD
COLD
NBIX
NBIX
Q2 26
24.3%
Q1 26
-2.4%
Q4 25
-13.7%
19.1%
Q3 25
-1.8%
26.4%
Q2 25
0.2%
15.6%
Q1 25
-2.7%
1.4%
Q4 24
-5.6%
16.4%
Q3 24
-0.6%
20.9%
EPS (diluted)
COLD
COLD
NBIX
NBIX
Q2 26
$1.91
Q1 26
$-0.05
Q4 25
$-0.31
$1.49
Q3 25
$-0.04
$2.04
Q2 25
$0.01
$1.06
Q1 25
$-0.06
$0.08
Q4 24
$-0.12
$1.00
Q3 24
$-0.01
$1.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLD
COLD
NBIX
NBIX
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$2.8B
$3.4B
Total Assets
$8.1B
$4.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLD
COLD
NBIX
NBIX
Q2 26
Q1 26
Q4 25
$136.9M
$713.0M
Q3 25
$33.3M
$340.2M
Q2 25
$101.4M
$264.0M
Q1 25
$38.9M
$194.1M
Q4 24
$47.7M
$233.0M
Q3 24
$61.3M
$349.1M
Stockholders' Equity
COLD
COLD
NBIX
NBIX
Q2 26
$3.4B
Q1 26
$2.8B
Q4 25
$2.9B
$3.3B
Q3 25
$3.0B
$3.0B
Q2 25
$3.1B
$2.7B
Q1 25
$3.2B
$2.5B
Q4 24
$3.3B
$2.6B
Q3 24
$3.4B
$2.7B
Total Assets
COLD
COLD
NBIX
NBIX
Q2 26
$4.9B
Q1 26
$8.1B
Q4 25
$8.1B
$4.6B
Q3 25
$8.1B
$4.3B
Q2 25
$8.1B
$3.9B
Q1 25
$7.8B
$3.7B
Q4 24
$7.7B
$3.7B
Q3 24
$7.9B
$3.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLD
COLD
NBIX
NBIX
Operating Cash FlowLast quarter
$39.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLD
COLD
NBIX
NBIX
Q2 26
Q1 26
$39.9M
Q4 25
$130.2M
$388.4M
Q3 25
$78.9M
$227.5M
Q2 25
$120.3M
$102.0M
Q1 25
$30.2M
$64.8M
Q4 24
$162.6M
$242.5M
Q3 24
$50.6M
$158.0M
Free Cash Flow
COLD
COLD
NBIX
NBIX
Q2 26
Q1 26
Q4 25
$-12.2M
$386.0M
Q3 25
$-65.4M
$214.3M
Q2 25
$-57.4M
$89.5M
Q1 25
$-82.3M
$54.1M
Q4 24
$57.4M
$235.2M
Q3 24
$-44.5M
$149.9M
FCF Margin
COLD
COLD
NBIX
NBIX
Q2 26
Q1 26
Q4 25
-1.9%
47.9%
Q3 25
-10.1%
27.0%
Q2 25
-9.0%
13.0%
Q1 25
-13.4%
9.4%
Q4 24
8.9%
37.5%
Q3 24
-6.7%
24.1%
Capex Intensity
COLD
COLD
NBIX
NBIX
Q2 26
Q1 26
2.2%
Q4 25
22.1%
0.3%
Q3 25
22.2%
1.7%
Q2 25
28.0%
1.8%
Q1 25
18.3%
1.9%
Q4 24
16.3%
1.2%
Q3 24
14.4%
1.3%
Cash Conversion
COLD
COLD
NBIX
NBIX
Q2 26
Q1 26
Q4 25
2.53×
Q3 25
1.09×
Q2 25
78.18×
0.95×
Q1 25
8.20×
Q4 24
2.35×
Q3 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLD
COLD

Warehouse services (3)$331.9M57%
Rent and storage$246.1M43%

NBIX
NBIX

INGREZZA Net Product Sales$656.9M81%
CRENESSITY Net Product Sales$153.3M19%
Other Revenues$4.3M1%

Related Comparisons